Organic ligand based on benzobithiadiazole structure and light-emitting metal organic framework material
By designing the synthesis of the organic ligand H4BTATA based on the benzobisthiadiazole structure and zirconium tetrachloride, HIAM-4030 material with infrared second-zone luminescence properties was prepared, which solved the problem of low luminescence brightness of the organic small molecule fluorophore, and realized the realization of the luminousness of the organic small molecule fluorophore. An organic ligand luminescent material in the NIR-II wavelength range with high brightness and stability, suitable for bioimaging.
Patent Information
- Application Number
- CN202410991165.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-23
- Publication Date
- 2024-11-15
AI Technical Summary
The luminous brightness of organic small molecule fluorophores in existing NIR-II fluorescence imaging materials is low and the application is limited, and the lack of reports on near-infrared two-zone luminescent metal organic framework materials (NIR-MOFs) based on organic ligands, limiting their inclusion in the Applications in the fields of bioimaging and medical diagnosis.
A benzobisthiadiazole-based organic ligand H4BTATA was designed and synthesized with zirconium tetrachloride to prepare a benzobisthiadiazole-based luminescent metal organic frame material HIAM-4030 with infrared two-zone luminescent properties. The maximum emission wavelength is 1050nm, and the topological structure and luminescence properties are regulated by optimizing the ligand structure.
A near-infrared two-zone luminescent metal organic frame material based on organic ligands is realized, with high brightness, stability and good biocompatibility, suitable for live biological imaging, and the organic ligand in the NIR-II wavelength range is realized for the first time. Luminous material.
Smart Images

Figure CN118955532A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of luminescent metal organic frameworks, in particular to an organic ligand based on a benzobithiadiazole structure and a luminescent metal organic framework material. Background Art
[0002] Compared with traditional diagnostic techniques such as CT and MRI, fluorescence imaging is widely used in in vivo imaging, clinical diagnosis, and cancer treatment due to its excellent temporal and spatial resolution, high sensitivity, and real-time dynamic in situ monitoring. Compared with the imaging windows of visible light (400-700nm) and near-infrared region I (NIR-I, 700-1000nm), near-infrared region II (NIR-II, 1000-1700nm) has a larger emission wavelength, which can effectively reduce the damage of the emitted light to the imaging tissue and reduce autofluorescence and light scattering. Therefore, NIR-II imaging has a higher signal-to-noise ratio, temporal and spatial resolution, and a deeper tissue imaging depth (5-20mm), making it more suitable for in vivo in situ imaging.
[0003] At present, the most widely studied NIR-II fluorescent imaging materials are mainly divided into two categories: inorganic fluorescent materials (such as single-walled carbon nanotubes, quantum dots and rare earth-doped nanoparticles, etc.) and organic fluorescent materials (copolymers, organic small molecule fluorophores and AIE molecules, etc.). Among them, organic small molecule fluorophores have shown outstanding advantages in fluorescence imaging due to their good compatibility in biological tissues, rapid metabolism, low toxicity, clear structure, easy modification and functionalization. However, due to problems such as low luminescence brightness, application scenarios or aggregation-induced luminescence quenching, their application is limited. Therefore, the development of high-brightness and high-stability NIR-II fluorescent imaging materials based on organic small molecules is still a research topic with great application prospects.
[0004] Luminescent Metal-Organic Frameworks (LMOFs) materials are an important member of Metal-Organic Frameworks (MOFs) materials. They have the characteristics of high stability, large specific surface area and porosity, clear pore structure and size, and easy surface functionalization. At the same time, their luminescent properties have been widely used in gas storage, adsorption and separation, catalysis and other fields, especially in sensing, detection, bioimaging, solid lighting and display devices. The fields have attracted more and more attention. The luminescence of LMOFs can come from central metal ions (such as rare earth metals), organic ligands or guest molecules, or through the interaction between guest molecules and metal ions or organic ligands. At present, most LMOFs are concentrated in the system with rare earth metals as the luminescence source. However, this type of material usually requires the addition of a sensitizer to achieve luminescence, and the luminescent wavelength is mostly concentrated in the visible light region, which greatly limits its application. LMOFs with organic ligands as luminescent centers have obvious advantages. The topological structure and luminescent properties (such as luminescent wavelength, fluorescence quantum yield, etc.) of LMOFs can be regulated through reasonable design and optimization of the organic ligand structure. The organic ligands can also be pre-functionalized or post-modified to meet the needs of various practical application scenarios, especially in the fields of bioimaging and medical diagnosis. However, there are no reports of NIR-MOFs in the prior art. Summary of the invention
[0005] The object of the present invention is to provide an organic ligand based on a benzobithiadiazole structure and a luminescent metal organic framework material.
[0006] In order to achieve the above object, the present invention adopts the following technical scheme: An organic ligand based on a benzobisthiadiazole structure comprises benzobisthiadiazole as an acceptor unit and a tertiary amine part as a donor unit. The donor unit is directly connected to the acceptor unit to reduce the distance between the two so as to obtain a larger light emission wavelength.
[0007] Further, the organic ligand is 4,4',4',4'-(benzo[1,2-c:1,2-c']bis([1,2,5]thiadiazole)-4,7-diyl)bis(azatriyl))-tetrabenzoic acid, with a molecular formula of H4BTATA and a chemical structural formula of:
[0008] Furthermore, the synthetic route of the organic ligand is:
[0009] In some embodiments, the method for synthesizing compound 2 is: take a relative amount of 10 to 12 mmol of compound 1, a relative amount of 5 to 6 mmol of 4,7-dibromo-5,6-dinitro-benzo[c][1,2,5]thiadiazole, a catalyst palladium acetate, an organic ligand tri-tert-butylphosphine tetrafluoroborate, and an organic base sodium tert-butoxide, mix them to form a reaction system, add the reaction system to an organic solvent and mix them thoroughly, heat the reaction under a nitrogen atmosphere for a predetermined time, cool to room temperature, distill under reduced pressure to remove the organic solvent, and then separate by chromatography to obtain a crude product of compound 2, which is directly used in the next reaction.
[0010] In some embodiments, the method for synthesizing compound 3 is: take compound 2 and reduced iron powder, add them to glacial acetic acid and mix them thoroughly, heat the reaction for a predetermined time under a nitrogen atmosphere, cool to room temperature, distill under reduced pressure to remove the organic solvent, and then separate by chromatography to obtain the target compound 3.
[0011] In some embodiments, the method for synthesizing compound 4 is: a relative amount of 0.1 to 0.2 mmol of N-sulfenylaniline and a relative amount of 0.3 to 0.5 mmol of compound 3 are added to pyridine to form a reaction mixture, the reaction mixture is heated to 80°C for a predetermined reaction time, and then trimethylsilyl chloride is added in a relative amount of 3 to 5 mmol. Under a nitrogen atmosphere, the reaction mixture is heated for a predetermined reaction time, the reaction mixture is cooled to room temperature, and the organic solvent is removed by distillation under reduced pressure to obtain a crude product of compound 4, which is directly used in the next step.
[0012] In some embodiments, the method for synthesizing the organic ligand H4BTATA based on the benzobithiadiazole structure is: In an ice-water bath, trifluoroacetic acid is added dropwise to a dichloromethane solution of compound 4 to obtain a reaction mixture, which is cooled to room temperature and stirred for a predetermined period of time. The organic solvent is removed by distillation under reduced pressure, the precipitate is filtered and washed with dichloromethane until the filtrate after washing has no obvious color, and the target compound H4BTATA is obtained after collection and vacuum drying.
[0013] The present invention also provides a luminescent metal organic framework material, which is a benzobisthiadiazole-based luminescent metal organic framework material synthesized from the organic ligand based on the benzobisthiadiazole structure described in any of the above embodiments and zirconium tetrachloride.
[0014] Furthermore, the benzobisthiadiazolyl-based luminescent metal-organic framework material is a 12-connected network structure, each of the organic ligands is connected to 4 Zr6 clusters, and each Zr6 cluster is coordinated with 12 of the organic ligands to form a ftw-type topological structure.
[0015] Furthermore, the molecular formula of the organic ligand is H4BTATA; the molecular formula of the benzobisthiadiazolyl-based luminescent metal organic framework material is Zr6O4(OH)4(BTATA)3, and its structural formula is:
[0016] Furthermore, the emission wavelength of the benzobisthiadiazole-based luminescent metal organic framework material belongs to the second infrared region; the maximum emission wavelength of the organic ligand framework material based on the benzobisthiadiazole structure is 1050nm, and the maximum absorption wavelength is 800nm.
[0017] Furthermore, the organic ligand is synthesized with zirconium oxide chloride octahydrate to obtain Nano-NIR-HIAM-4030MOFs with a particle size of 200-300 nm.
[0018] The benzobisthiadiazolyl-based luminescent metal organic framework material is HIAM-4030, and its synthesis method is as follows: A relative amount of 0.05 mmol to 0.15 mmol of zirconium tetrachloride as a zirconium source, a relative amount of 5 to 15 mg of an organic ligand and a regulator benzoic acid are added to an organic solvent DMF to form a mixture, and the mixture is heated to react for a predetermined time to obtain crystalline HIAM-4030; or A relative amount of 15-25 mg of zirconium oxide chloride octahydrate, a relative amount of 5-15 mg of an organic ligand and a regulator benzoic acid are added to an organic solvent DMF to form a mixture, and the mixture is heated to react for a predetermined time to obtain a product Nano-HIAM-4030.
[0019] The beneficial effects of the present invention are:
[0020] The luminescent metal organic framework material of the present invention is a benzobisthiadiazolyl-based near-infrared second-zone luminescent metal organic framework material, which is based on organic ligand luminescent NIR-MOFs and has the following advantages: (1) There are many types of organic small molecule fluorophores with clear structures and easy modification and functionalization; (2) The topological structure and luminescence properties of the ligand can be regulated by designing and optimizing the ligand; (3) It has good compatibility, rapid metabolism and low toxicity in biological tissues, making it more suitable for in vivo biological imaging. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 It is the molecular structure measured by the single crystal X-ray image of the benzobisthiadiazolyl-based near-infrared second-zone luminescent metal-organic framework material according to the embodiment of the present invention.
[0022] Figure 2It is a schematic diagram of the molecular structure of a benzobisthiadiazolyl-based near-infrared second-zone luminescent metal-organic framework material according to an embodiment of the present invention.
[0023] Figure 3 It is the fluorescence spectrum and ultraviolet-visible light absorption spectrum of the benzobisthiadiazolyl-based near-infrared second-zone luminescent metal organic framework material of the embodiment of the present invention.
[0024] Figure 4 This is a scanning electron microscope photograph of the nano-benzobisthiadiazolyl-based near-infrared second-zone luminescent metal-organic framework material according to an embodiment of the present invention. DETAILED DESCRIPTION
[0025] The exemplary embodiments of the present application will be described in more detail below with reference to the accompanying drawings. Although the exemplary embodiments of the present application are shown in the accompanying drawings, it should be understood that the present application can be implemented in various forms and should not be limited by the embodiments described herein. On the contrary, these embodiments are provided in order to enable a more thorough understanding of the present application and to fully convey the scope of the present application to those skilled in the art.
[0026] It should be understood that the terms used herein are only for the purpose of describing specific example embodiments and are not intended to be limiting. Unless the context clearly indicates otherwise, the singular forms "one", "an" and "said" as used herein may also be meant to include plural forms. The terms "include", "comprise", "contain", and "have" are inclusive, and therefore specify the existence of stated features, steps, operations, elements and / or parts, but do not exclude the existence or addition of one or more other features, steps, operations, elements, parts, and / or combinations thereof. The method steps, processes, and operations described herein are not interpreted as necessarily requiring them to be performed in the specific order described or illustrated, unless the execution order is clearly indicated. It should also be understood that additional or alternative steps may be used.
[0027] The experimental methods described in the following examples are conventional methods unless otherwise specified; the reagents and materials described are commercially available unless otherwise specified.
[0028] The endpoints and any values of the endpoint values disclosed in the present invention are not limited to the precise range or value, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of each range, the endpoint values of each range and the individual point values, and the individual point values can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.
[0029] The present invention relates to an organic ligand based on a benzobisthiadiazole structure and a luminescent metal organic framework material, wherein the organic ligand based on the benzobisthiadiazole structure is abbreviated as H4BTATA, and includes benzobisthiadiazole as an acceptor unit and a tertiary amine part as a donor unit, and the donor unit is directly connected to the acceptor unit to reduce the distance between the two to obtain a larger light emission wavelength. H4BTATA is used to prepare LMOFs, and the LMOFs synthesized by the organic ligand H4BTATA and zirconium tetrachloride are benzobisthiadiazole-based luminescent metal organic framework materials, abbreviated as HIAM-4030MOFs, with a maximum emission wavelength of 1050nm, and nano-sized, realizing the preparation of LMOFs materials based on organic ligand luminescence and luminescence wavelength in NIR-II for the first time.
[0030] The present invention starts from the perspective of molecular design and synthesizes a novel tetracarboxylic acid organic ligand 4,4',4',4'-(benzo[1,2-c:1,2-c']bis([1,2,5]thiadiazole)-4,7-diyl)bis(azanetriyl))-tetrabenzoic acid (4,4',4",4"'-((benzo[1,2-c:1,2-c']bis([1,2,5]thiadiazole)-4,7-diyl)bis(azanetriyl))-tetrabenzoic acid, H4BTATA), the chemical structure of which is as follows:
[0031] In this structure, benzobisthiadiazole is the acceptor unit, and the tertiary amine part is the donor unit. The donor unit and the acceptor unit are directly connected to reduce the distance between the two, in the hope of obtaining a larger emission wavelength.
[0032] The synthetic route of compound H4BTATA is shown in the figure below:
[0033] The synthesis method of compound 2 (tetrakis(2-(trimethylsilyl)ethyl)4,4',4",4"'-((5,6-dinitrobenzo[c][1,2,5]thiadiazole-4,7-diyl)bis(azanetriyl))tetrabenzoate, 4,7-bis(4,4'-dibenzoic acid (2-trimethylsilyl)ethyl ester)amino-5,6-dinitrobenzo[c][1,2,5]thiadiazole) is as follows: Weigh compound 1 (bis(2-(trimethylsilyl)ethyl)4,4'-azanediyldibenzoate, 4,4'-iminodibenzoic acid (2-trimethylsilyl)ethyl ester) (relative amount 5-6 g, 10-12 mmol), 4,7-dibromo-5,6-dinitro-benzo[c][1,2,5]thiadiazole (relative amount 2-3 g, 5-6 mmol), catalyst palladium acetate (relative amount 50-60 mg, 0.2-0.3 mmol), organic ligand tri-tert-butylphosphine tetrafluoroborate (relative amount 200-300 mg, 0.7-0.8 mmol), organic base sodium tert-butoxide (relative amount 1-2 g, 10-20 mmol) in a 250 mL three-necked flask, and replace with vacuum-nitrogen three times. Subsequently, add 100-200 mL of anhydrous toluene as an organic solvent to the reaction system, heat the reaction under a nitrogen atmosphere, and track the reaction by TLC. After the reaction was completed, the reaction mixture was cooled to room temperature, the organic solvent was distilled off under reduced pressure, and the residue was separated by flash column chromatography to obtain a crude product, which was directly used in the next reaction without further purification.
[0034] The synthesis method of compound 3 (tetrakis(2-(trimethylsilyl)ethyl)4,4',4",4"'-((5,6-diaminobenzo[c][1,2,5]thiadiazole-4,7-diyl)bis(azanetriyl))tetrabenzoate,4,7-bis(4,4'-dibenzoic acid (2-trimethylsilyl)ethyl ester)amino-5,6-diaminobenzo[c][1,2,5]thiadiazole) is as follows: Weigh compound 2 (relative amount 2-3g, 2-3mmol), reduced iron powder (relative amount 1-2g, 20-30mmol) in a 100mL round-bottom flask, add 20-40mL glacial acetic acid as an organic solvent, and replace with vacuum-nitrogen three times. Heat to 100°C under nitrogen atmosphere to react overnight, cool to room temperature, remove organic solvent by vacuum distillation, and separate the residue by rapid column chromatography to obtain target compound 3 (yellow powder, 1.22g, yield: 56%). The results of H nuclear magnetic resonance spectrum detection of the product were: 1H NMR (400 MHz, CDCl3) δH (ppm) = 7.95 (d, J = 8.8 Hz, 8H), 7.15 (d, J = 8.8 Hz, 8H), 4.37 (t, J = 8.4 Hz, 8H), 4.19 (br, 4H), 1.09 (t, J = 8.4 Hz, 8H), 0.06 (s, 36H). 13C NMR (101 MHz, CDCl3) δC (ppm) = 166.3, 149.5, 148.8, 139.4, 131.4, 125.2, 120.3, 116.5, 63.2, 17.5, -1.3; thus verifying that the obtained product is compound 3.
[0035] The synthesis method of compound 4 (tetrakis(2-(trimethylsilyl)ethyl)4,4',4",4"'-((benzo[1,2-c:1,2-c']bis([1,2,5]thiadiazole)-4,7-diyl)bis(azanetriyl))tetrabenzoate,4,7-bis(4,4'-dibenzoic acid (2-trimethylsilyl)ethyl ester)aminobenzo[1,2-c:4,5-c']bis([1,2,5]thiadiazole)) is as follows: N-sulfenylanilide (relative amount of 100-150 μL, 0.1-0.2 mmol) was added to an anhydrous pyridine solution containing compound 3 (relative amount of 300-500 mg, 0.3-0.5 mmol), and the reaction mixture was heated to 80 ° C for 5 minutes. Subsequently, trimethylsilyl chloride (relative amount of 300-500 μL, 3-5 mmol) was added to the above reaction system. After heating the reaction for 24-48 hours under a nitrogen atmosphere, the reaction mixture was cooled to room temperature, and the organic solvent was removed by distillation under reduced pressure. The crude product was directly used in the next step without further separation and purification. The results of H nuclear magnetic resonance spectrum detection of the product were: 1H NMR (400 MHz, CDCl3) δH (ppm) = 7.95 (d, J = 8.8 Hz, 8H), 7.11 (d, J = 8.8 Hz, 8H), 4.39 (t, J = 8.4 Hz, 8H), 1.10 (t, J = 8.4 Hz, 8H), 0.07 (s, 36H). 13C NMR (101 MHz, CDCl3) δC (ppm) = 166.3, 151.3, 150.5, 131.1, 126.0, 122.7, 121.9, 63.3, 17.5, -1.3; thus verifying that the obtained product is compound 4.
[0036] The synthesis method of the compound H4BTATA (4,4',4',4'-(benzo[1,2-c:1,2-c']bis([1,2,5]thiadiazole)-4,7-diyl)bis(azatriyl))-tetrabenzoic acid) is as follows: In an ice-water bath, 10-20 mL of trifluoroacetic acid was added dropwise to a dichloromethane solution of compound 4 (from the previous step). After the addition was complete, the reaction mixture was cooled to room temperature and stirred overnight. Subsequently, the organic solvent was removed by distillation under reduced pressure, and the precipitate was filtered and washed with dichloromethane until the filtrate had no obvious color. The target compound H4BTATA (blue-green powder, 169.9 mg, two-step yield: 41%) was obtained after collection and vacuum drying. The results of H NMR spectrum detection of the product were: 1H NMR (400 MHz, CDCl3) δH (ppm) = 12.70 (br, 4H), 7.80 (d, J = 8.8 Hz, 8H), 7.21 (d, J = 8.8 Hz, 8H). 13C NMR (101 MHz, CDCl3) δC (ppm) = 167.4, 152.1, 150.6, 131.3, 125.8, 122.7, 122.0; thus verifying that the obtained product is compound H4BTATA.
[0037] The synthesis method of NIR-HIAM-4030MOFs is as follows: In a 5mL vial, zirconium tetrachloride (relative amount of 0.05mmol-0.15mmol, 11.6mg-34.9mg), organic ligand H4BTATA (relative amount of 5-15mg), regulator benzoic acid (relative amount of 650-750mg) and 3mL N,N-dimethylformamide (DMF) as an organic solvent were added. The mixture was heated in an oven at 120°C for 3 days. The dark green crystalline luminescent metal organic framework material obtained after the reaction was completed was specifically a benzobisthiadiazolyl near-infrared second-zone luminescent metal organic framework material, HIAM-4030 (HIAM: Hoffmann Institute of Advanced Materials, Hoffmann Institute of Advanced Materials; 40: Zirconium, zirconium).
[0038] HIAM-4030 is a porous material with the molecular formula Zr6O4(OH)4(BTATA)3. Its structural formula can be used Figure 1 or Figure 2 To express.
[0039] Single crystal X-ray analysis, reference Figure 1 As shown, the crystal structure of HIAM-4030 (benzobisthiadiazolyl near-infrared second-zone luminescent metal-organic framework material). Specifically, the synthesized HIAM-4030 is a 12-connected network structure, each H4BTATA ligand is connected to 4 Zr6 clusters, and each Zr6 cluster is coordinated with 12 H4BTATA ligands to form a ftw-type topological structure.
[0040] Characterization of the luminescence properties of HIAM-4030, refer to Figure 3 The fluorescence spectrum and UV-visible absorption spectrum shown in the figure indicate that the maximum emission wavelength of HIAM-4030 (benzobisthiadiazolyl-based near-infrared second-zone luminescent metal-organic framework material) is 1050 nm, which belongs to the near-infrared second-zone luminescence range, and the maximum absorption wavelength is around 800 nm.
[0041] The synthesis method of Nano-NIR-HIAM-4030MOFs is as follows: In a 5mL vial, zirconium source chloride zirconium oxide (IV) octahydrate (relative amount of 15-25mg), H4BTATA (relative amount of 5-15mg), regulator benzoic acid (relative amount of 200-300mg) and 3mL DMF as an organic solvent were added. The mixture was stirred and heated in a heating module at 95°C for 4h to obtain the product nano-HIAM-4030 (nano-benzobisthiadiazolyl near-infrared second-zone luminescent metal organic framework material).
[0042] SEM test image of Nano-NIR-HIAM-4030 Figure 4 The particle size is 200-300nm, which means that HIAM-4030 can be nanosized.
[0043] The present invention designs and synthesizes a tetracarboxylic acid organic ligand H4BTATA with benzobithiadiazole as an acceptor unit and tertiary amine as a donor unit, and the donor and the acceptor are directly connected, and applies it to the preparation of LMOFs. The prepared LMOFs have a maximum emission wavelength of 1050nm, and are nano-sized, realizing the preparation of LMOFs materials based on organic ligand luminescence and luminescence wavelength in NIR-II for the first time.
[0044] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of protection of the present invention is defined by the appended claims and their equivalents.
Claims
1. An organic ligand based on a benzobisthiadiazole structure, comprising benzobisthiadiazole as an acceptor unit and a tertiary amine portion as a donor unit, wherein the donor unit is directly connected to the acceptor unit to reduce the distance between the two so as to obtain a larger light emission wavelength.
2. The organic ligand according to claim 1, characterized in that: The organic ligand is 4,4',4',4'-(benzo[1,2-c:1,2-c']bis([1,2,5]thiadiazole)-4,7-diyl)bis(azatriyl))-tetrabenzoic acid, with a molecular formula of H4BTATA and a chemical structural formula of:
3. The organic ligand according to claim 2, characterized in that: The synthetic route of the organic ligand is:
4. The organic ligand according to claim 3, characterized in that: The method for synthesizing compound 2 is: taking a relative amount of 10 to 12 mmol of compound 1, a relative amount of 5 to 6 mmol of 4,7-dibromo-5,6-dinitro-benzo[c][1,2,5]thiadiazole, a catalyst of palladium acetate, an organic ligand of tri-tert-butylphosphine tetrafluoroborate, and an organic base of sodium tert-butoxide, and mixing them to form a reaction system; adding the reaction system to an organic solvent and mixing them thoroughly; heating the reaction under a nitrogen atmosphere for a predetermined time; cooling to room temperature; removing the organic solvent by distillation under reduced pressure; and separating by chromatography to obtain a crude product of compound 2, which is directly used in the next step of reaction; The method for synthesizing compound 3 is as follows: compound 2 and reduced iron powder are added to glacial acetic acid and mixed thoroughly, heated for a predetermined reaction time under a nitrogen atmosphere, cooled to room temperature, and the organic solvent is removed by vacuum distillation, and then separated by chromatography to obtain the target compound 3; The method for synthesizing compound 4 is as follows: a relative amount of 0.1 to 0.2 mmol of N-sulfenylanilide and a relative amount of 0.3 to 0.5 mmol of compound 3 are added to pyridine to form a reaction mixture, the reaction mixture is heated to 80° C. for a predetermined reaction time, and then a relative amount of 3 to 5 mmol of trimethylsilyl chloride is added, and the reaction is heated under a nitrogen atmosphere for a predetermined reaction time, the reaction mixture is cooled to room temperature, and the organic solvent is removed by distillation under reduced pressure to obtain a crude product of compound 4, which is directly used in the next step; The method for synthesizing the organic ligand H4BTATA based on the benzobithiadiazole structure is: In an ice-water bath, trifluoroacetic acid is added dropwise to a dichloromethane solution of compound 4 to obtain a reaction mixture, which is cooled to room temperature and stirred for a predetermined period of time. The organic solvent is removed by distillation under reduced pressure, the precipitate is filtered and washed with dichloromethane until the filtrate after washing has no obvious color, and the target compound H4BTATA is obtained after collection and vacuum drying.
5. A luminescent metal organic framework material, which is a benzobisthiadiazole-based luminescent metal organic framework material synthesized from the organic ligand based on the benzobisthiadiazole structure according to any one of claims 1 to 4 and zirconium tetrachloride.
6. The luminescent metal organic framework material according to claim 5, characterized in that: The benzobisthiadiazolyl-based luminescent metal organic framework material is a 12-connected network structure, each of the organic ligands is connected to 4 Zr6 clusters, and each Zr6 cluster is coordinated with 12 organic ligands to form a ftw-type topological structure.
7. The luminescent metal organic framework material according to claim 6, characterized in that: The molecular formula of the organic ligand is H4BTATA; the molecular formula of the benzobisthiadiazolyl-based luminescent metal organic framework material is Zr6O4(OH)4(BTATA)3, and its structural formula is:
8. The luminescent metal organic framework material according to claim 5, characterized in that: The emission wavelength of the benzobisthiadiazolyl-based luminescent metal organic framework material belongs to the second infrared region; The organic ligand framework material based on the benzobisthiadiazole structure has a maximum emission wavelength of 1050 nm and a maximum absorption wavelength of 800 nm.
9. The luminescent metal organic framework material according to claim 5, characterized in that: The organic ligand is synthesized with zirconium oxide chloride octahydrate to obtain Nano-NIR-HIAM-4030MOFs, and the particle size is 200-300nm.
10. The luminescent metal organic framework material according to claim 5, characterized in that: The benzobisthiadiazolyl-based luminescent metal organic framework material is HIAM-4030, and its synthesis method is as follows: A relative amount of 0.05 mmol to 0.15 mmol of zirconium tetrachloride as a zirconium source, a relative amount of 5 to 15 mg of an organic ligand and a regulator benzoic acid are added to an organic solvent DMF to form a mixture, and the mixture is heated to react for a predetermined time to obtain crystalline HIAM-4030; or A relative amount of 15-25 mg of zirconium oxide chloride octahydrate, a relative amount of 5-15 mg of an organic ligand and a regulator benzoic acid are added to an organic solvent DMF to form a mixture, and the mixture is heated to react for a predetermined time to obtain a product Nano-HIAM-4030.
